Seqens

Seqens

X

Find the latest and updated news about Malladi Drugs & Pharmaceuticals Limited aggregated by PharmaCompass.com.

Malladi Drugs & Pharmaceuticals Limited
News
Full Screen View

Malladi Drugs & Pharmaceuticals Limited

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2022, Corporate Presentation, Intermediates Product List 2022, GMP Certificate 2014, Phenylephrine HCl CFDA, Product List 2020

VIDEO(s)

No Video

DIGITAL CONTENT

5 News

5 News

APIs // Active Pharmaceutical Ingredients

54 APIs, 22 USDMF, 5 CEP/COS, 16 EU WC, 8 KDMF, 22 NDC API, 41 Listed APIs

DEVELOPMENTS

No Content

KEY PRODUCTS

Alprazolam, Butorphanol, Epinephrine, Epinephrine Bitartrate, Lorazepam, Norepinephrine, Norepinephrine Bitartrate, Tetrahydrocannabinol

INTERMEDIATES

44 Listed Products

44 Listed Products

SERVICES

All Services, API Manufacturing, API & Drug Product Development

All Services
API Manufacturing
API & Drug Product Development
- 3 API Development

INSPECTIONS & REGISTRATIONS

11 FDA, 1 EDQM, 2 WHO-GMP, 2 GDUFA

News

All Pharma News

price-trend

InvAscent invests Rs 250 cr in Malladi Drugs

InvAscent invests Rs 250 cr in Malladi Drugs

Yogesh Kabirdoss TIMESOFINDIA

26 Apr 2022

Bulk drugs sector may soon see flurry of deals

Bulk drugs sector may soon see flurry of deals

LIVEMINT

16 Oct 2021

Four accused arrests in Alphazone sedative drug stealing case

Four accused arrests in Alphazone sedative drug stealing case

THEHAAINDIA

18 May 2019

Share

Malladi Drugs & Pharmaceuticals Receives FDA Warning Letter

FDA

21 Mar 2018

Share

Dutch firm Corbion buys lactic acid business of Malladi Specialties

Dutch firm Corbion buys lactic acid business of Malladi Specialties

Rakesh Rao BUSINESS-STANDARD

23 Sep 2015